TABLE 6.
MARS-5 as Compared to Medication Monitoring Adherence ≥80% and ≥90%
| MARS-5 | Adherence ≥80%* | Adherence ≥90%† | ||
|---|---|---|---|---|
| Sensitivity | Specificity | Sensitivity | Specificity | |
| >15 | 100% | 9.1% | 100% | 5.0% |
| >16 | 100% | 18.2% | 100% | 10.0% |
| >17 | 99.0% | 18.2% | 98.9% | 10.0% |
| >18 | 97.9% | 27.3% | 98.9% | 20.0% |
| >19 | 95.9% | 27.3% | 96.6% | 20.0% |
| >20 | 92.8% | 54.6% | 93.2% | 35.0% |
| >21 | 87.6% | 54.6% | 87.5% | 35.0% |
| >22‡ | 82.5%‡ | 81.8%‡ | 85.2% | 65.0% |
| >23§ | 69.1% | 100% | 70.5%§ | 75.0%§ |
| >24 | 55.7% | 100% | 59.1% | 90.0% |
| >25 | 35.1% | 100% | 26.4% | 90.0% |
*C-statistic = 0.898.
†C-statistic = 0.794.
‡Numbers represent optimal cutoff point for adherence ≥80%.
§Numbers represent optimal cutoff point for adherence ≥90%.